1
Apomorphine Effects on Experimental Pain
Condition(s):HealthyLast Updated:September 16, 2016Completed
Apomorphine as an Intervention: 52 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
Infusion of Apomorphine: Long-term Safety Study
Condition(s):Idiopathic Parkinson’s DiseaseLast Updated:November 30, 2020Active, not recruiting
3
Apomorphine Pump in Early Stage of Parkinson’s Disease (EARLY-PUMP)
Condition(s):Parkinson’s DiseaseLast Updated:October 20, 2021Recruiting
4
Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:February 10, 2021Active, not recruiting
5
Comparison of Continuous and Pulsatile Apomorphine in Parkinson’s Disease
Condition(s):Parkinson’s DiseaseLast Updated:November 2, 2018Withdrawn
6
Treating Severe Brain-injured Patients With Apomorphine
Condition(s):Disorder of ConsciousnessLast Updated:January 10, 2020Recruiting
7
A Study of an Investigational Drug to See How it Affects the People With Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes) Compared to an Approved Drug Used to Treat People With Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes)
Condition(s):Motor OFF Episodes Associated With Parkinson’s DiseaseLast Updated:November 18, 2021Recruiting
8
Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:September 20, 2021Recruiting
9
A Study to Examine APL-130277 in Patients With Parkinson’s Disease
Condition(s):Parkinson’s DiseaseLast Updated:July 30, 2020Completed
10
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of “OFF” Episodes in Patients With Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:November 2, 2021Recruiting